Vaishali Pharma Limited is listed on the NSE. Auto-imported from the NSE equity master; profile pending.
1,938 historical price candles were omitted because the exchange source has not been verified.
No positive flags triggered.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
Consolidated figures
| Ratio | Mar 2026 |
|---|---|
| Margins | |
| Gross margin % | 12.5% |
| EBITDA margin % | 3.8% |
| EBIT margin % | 3.2% |
| PAT margin % | 3.8% |
| Working capital | |
| Receivable days | 170 |
| Inventory days | 13 |
| Payable days | 81 |
| NWC days | 102 |
| Leverage | |
| Current ratio | 2.34 |
| Debt to EBITDA | 4.51 |
| Debt to equity | 0.27 |
| Interest coverage | 3.8 |
| Asset turnover | 0.88 |
| Return ratios | |
| Return on assets % | 3.4% |
| Return on capital employed % | 9.8% |
| Return on equity % | 6% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
No scheme among the 32 fund houses on record reported a position in Vaishali Pharma Limited. Portfolios are published monthly by each AMC; coverage is still partial.
Annual reports, earnings call transcripts and presentations will appear here once ingested.
Quarterly shareholding records haven't been ingested for this company.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| A-One Steels India LimitedAONESTEELSAONESTEELS | ₹3,198 Cr | ₹4,209 Cr | ₹4,149 Cr | ₹285 Cr | 6.9% | ₹126 Cr | 3.1% | 19.3% | 16.5% | — |
| Anawil Wire And Engineering LimitedANAWILANAWIL | ₹1,064 Cr | — | — | — | — | — | — | — | — | — |
| Credent Connect N Care LimitedCREDENTCREDENT | ₹696 Cr | — | — | — | — | — | — | — | — | — |
| Metalic Technoforge LimitedMETALICMETALIC | ₹426 Cr | — | — | — | — | — | — | — | — | — |
| Optimystix Entertainment India LimitedOPTIMYSTIXOPTIMYSTIX | ₹307 Cr | — | — | — | — | — | — | — | — | — |
| Pramodini Medicare LimitedPRAMODINIPRAMODINI | ₹254 Cr | ₹271 Cr | ₹62 Cr | — | — | ₹17 Cr | 27.9% | -11.3% | 39.1% | — |
| Annapurna Swadisht LimitedANNAPURNAANNAPURNA | ₹211 Cr | — | ₹520 Cr | ₹72 Cr | 13.9% | ₹32 Cr | 6.2% | — | — | — |
| Fascinate Textiles LimitedFASCINATEFASCINATE | ₹102 Cr | — | — | — | — | — | — | — | — | — |
| Propshop Events And Exhibitions LimitedPROPSHOPPROPSHOP | ₹97 Cr | — | ₹70 Cr | ₹11 Cr | 15.8% | ₹8 Cr | 11.4% | — | — | — |
| Vinod Texworld LimitedVINODVINOD | ₹82 Cr | — | — | — | — | — | — | — | — | — |
| Skytech Infinite Platform LimitedSKYTECHSKYTECH | ₹38 Cr | ₹44 Cr | — | — | — | — | — | — | — | — |
| Dhansa Labs LimitedDHANSADHANSA | — | — | ₹142 Cr | ₹11 Cr | 7.7% | ₹6 Cr | 3.9% | — | — | — |
Consolidated figures · ₹ crore
| ₹ Cr | Mar 2026 |
|---|---|
| Revenue | 109 |
| COGS | 95 |
| Gross profit | 14 |
| 9 | |
| 4 | |
| OPM % | 3.9% |
| Depreciation | 1 |
| Interest | 2 |
| 4 | |
| Profit before tax | 6 |
| Tax | 1 |
| Tax % | 24.6% |
| PAT | 4 |
| PAT margin % | 3.8% |
| EPS (₹) | 0.3 |
| EPS adjusted (₹) | 0.3 |
| ₹ Cr | Mar 2026 |
|---|---|
| Equity capital | 26 |
| Reserves | 43 |
| Minority interest | 0 |
| 19 | |
| 36 | |
| Total equity & liabilities | 123 |
| 2 | |
| CWIP | — |
| Investments | 6 |
| 116 | |
| Total assets | 123 |
| ₹ Cr | Mar 2026 |
|---|---|
| 0 | |
| -5 | |
| 5 | |
| Net cash flow | -0 |
| Free cash flow | -0 |
| CFO / Operating profit % | 10.7% |